Shah BD, Cassaday RD, Park JH, Houot R, et al. Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3. Leukemia 2025 Mar 19. doi: 10.1038/s41375-025-02532.
PMID: 40108332